Project Details
| Status | Active |
|---|---|
| Effective start/end date | 9/29/21 → … |
EF-32 - TRIDENT A Pivotal Randomized, Open-label Study of Optune® (TTFields, 200kHz) Concomitant with Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
- Baskin, David S. (Key Personnel)
- Farach, Andrew M. (Key Personnel)
- Haque, Waqar M. (Key Personnel)
- Teh, Bin S. (Key Personnel)
Project: Clinical Trial